- Home
- SNOA vs PMAX Comparison
SNOA vs PMAX Comparison
Compare SNOA & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- PMAX
- Stock Information
- Founded
- SNOA 1999
- PMAX 2019
- Country
- SNOA United States
- PMAX Hong Kong
- Employees
- SNOA N/A
- PMAX N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- SNOA Health Care
- PMAX
- Exchange
- SNOA Nasdaq
- PMAX Nasdaq
- Market Cap
- SNOA 6.9M
- PMAX 6.9M
- IPO Year
- SNOA 2007
- PMAX 2024
- Fundamental
- Price
- SNOA $4.00
- PMAX $2.74
- Analyst Decision
- SNOA
- PMAX
- Analyst Count
- SNOA 0
- PMAX 0
- Target Price
- SNOA N/A
- PMAX N/A
- AVG Volume (30 Days)
- SNOA 76.8K
- PMAX 1.5M
- Earning Date
- SNOA 11-07-2025
- PMAX 09-23-2025
- Dividend Yield
- SNOA N/A
- PMAX N/A
- EPS Growth
- SNOA N/A
- PMAX N/A
- EPS
- SNOA N/A
- PMAX N/A
- Revenue
- SNOA $14,912,000.00
- PMAX $4,799,100.00
- Revenue This Year
- SNOA $23.00
- PMAX N/A
- Revenue Next Year
- SNOA $24.59
- PMAX N/A
- P/E Ratio
- SNOA N/A
- PMAX N/A
- Revenue Growth
- SNOA 17.43
- PMAX N/A
- 52 Week Low
- SNOA $1.75
- PMAX $1.87
- 52 Week High
- SNOA $6.92
- PMAX $30.24
- Technical
- Relative Strength Index (RSI)
- SNOA 49.74
- PMAX 62.69
- Support Level
- SNOA $3.57
- PMAX $2.52
- Resistance Level
- SNOA $4.02
- PMAX $3.03
- Average True Range (ATR)
- SNOA 0.23
- PMAX 0.44
- MACD
- SNOA 0.00
- PMAX -0.08
- Stochastic Oscillator
- SNOA 58.63
- PMAX 10.77
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.